17 Dec Aegis Sciences Corporation Collaborates with The McNabb Center to Evaluate the Impact of Xylazine Exposure on Opioid Withdrawal
NASHVILLE, TN. (December 17, 2024) – In April 2023, the White House designated the combination of fentanyl and xylazine as an emerging...